Hyperfunctioning thyroid carcinoma: A systematic review

Liu,Jun; Wang,Ye; Da,Dongzhu; Zheng,Miao

doi:10.3892/mco.2019.1927

Hyperfunctioning thyroid carcinoma: A systematic review

Authors:
- Jun Liu
- Ye Wang
- Dongzhu Da
- Miao Zheng
View Affiliations

Affiliations: Department of Breast‑Thyroid Surgery, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 201620, P.R. China
Published online on: October 1, 2019 https://doi.org/10.3892/mco.2019.1927
Pages: 535-550
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hyperthyroidism may be caused by the development of primary or metastatic thyroid carcinoma. The aim of the present study was to collect recently reported cases of hyperfunctioning thyroid carcinoma in order to analyze its pathological characteristics, diagnostic procedures and treatment strategies. A PubMed (https://www.ncbi.nlm.nih.gov/pubmed/) search was performed for studies published between January 1990 and July 2017. Full‑text articles were identified using the terms, ‘hyperfunctioning thyroid carcinoma/cancer’, ‘malignant hot/toxic thyroid nodule’, or ‘hyperfunctioning papillary/follicular/Hürthle thyroid carcinoma’. Original research papers, case reports and review articles were included. Among all thyroid carcinoma cases included in the present study, the prevalence of follicular thyroid carcinoma (FTC) was ~10%; however, the prevalence of FTC among hyperfunctioning thyroid carcinomas was markedly higher (46.5% in primary and 71.4% in metastatic disease). The size of hyperfunctioning thyroid tumors was considerably larger compared with that of non‑hyperfunctioning thyroid tumors, with a mean size of 4.25±2.12 cm in primary hyperfunctioning thyroid carcinomas. In addition, in cases of metastatic hyperfunctioning thyroid carcinoma, tumor metastases were widespread or large in size. The diagnosis of primary hyperfunctioning thyroid carcinoma is based on the following criteria: i) No improvement in thyrotoxicosis following radioactive iodine (RAI) treatment; ii) development of hypoechoic solid nodules with microcalcifications on ultrasound examination; iii) increase in tumor size over a short time period; iv) fixation of the tumor to adjacent structures; and v) signs/symptoms of tumor invasion. The diagnosis of metastatic hyperfunctioning thyroid carcinoma should be considered in patients suffering from thyrotoxicosis who present with a high number of metastatic lesions (as determined by whole‑body scanning), or a history of total thyroidectomy. Surgery is the first‑line treatment option for patients with primary hyperfunctioning thyroid carcinoma, as it does not only confirm the diagnosis following pathological examination, but also resolves thyrotoxicosis and is a curative cancer treatment. RAI is a suitable treatment option for patients with hyperfunctioning thyroid carcinoma who present with metastatic lesions.

View Figures

View References

1	Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, et al: 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI
2	Pazaitou-Panayiotou K, Michalakis K and Paschke R: Thyroid cancer in patients with hyperthyroidism. Horm Metab Res. 44:255–262. 2012. View Article : Google Scholar : PubMed/NCBI
3	Als C, Gedeon P, Rösler H, Minder C, Netzer P and Laissue JA: Survival analysis of 19 patients with toxic thyroid carcinoma. J Clin Endocrinol Metab. 87:4122–4127. 2002. View Article : Google Scholar : PubMed/NCBI
4	Qiu ZL, Shen CT and Luo QY: Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy. Thyroid. 25:229–237. 2015. View Article : Google Scholar : PubMed/NCBI
5	Mirfakhraee S, Mathews D, Peng L, Woodruff S and Zigman JM: A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: Review of the literature. Thyroid Res. 6:72013. View Article : Google Scholar : PubMed/NCBI
6	Appetecchia M and Ducci M: Hyperfunctioning differentiated thyroid carcinoma. J Endocrinol Invest. 21:189–192. 1998. View Article : Google Scholar : PubMed/NCBI
7	Mircescu H, Parma J, Huot C, Deal C, Oligny LL, Vassart G and Van Vliet G: Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: Pathologic and molecular studies. J Pediatr. 137:585–587. 2000. View Article : Google Scholar : PubMed/NCBI
8	Bourasseau I, Savagner F, Rodien P, Duquenne M, Reynier P, Guyetant S, Bigorgne JC, Malthièry Y and Rohmer V: No evidence of thyrotropin receptor and G(s alpha) gene mutation in high iodine uptake thyroid carcinoma. Thyroid. 10:761–765. 2000. View Article : Google Scholar : PubMed/NCBI
9	Camacho P, Gordon D, Chiefari E, Yong S, DeJong S, Pitale S, Russo D and Filetti S: A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid. 10:1009–1012. 2000. View Article : Google Scholar : PubMed/NCBI
10	Führer D, Tannapfel A, Sabri O, Lamesch P and Paschke R: Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases. Endocr Relat Cancer. 10:591–600. 2003. View Article : Google Scholar : PubMed/NCBI
11	Wong CP, AuYong TK and Tong CM: Thyrotoxicosis: A rare presenting symptom of Hurthle cell carcinoma of the thyroid. Clin Nucl Med. 28:803–806. 2003. View Article : Google Scholar : PubMed/NCBI
12	Gozu H, Avsar M, Bircan R, Claus M, Sahin S, Sezgin O, Deyneli O, Paschke R, Cirakoglu B and Akalin S: Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules. Thyroid. 15:389–397. 2005. View Article : Google Scholar : PubMed/NCBI
13	Majima T, Doi K, Komatsu Y, Itoh H, Fukao A, Shigemoto M, Takagi C, Corners J, Mizuta N, Kato R and Nakao K: Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule. Endocr J. 52:309–316. 2005. View Article : Google Scholar : PubMed/NCBI
14	Bitterman A, Uri O, Levanon A, Baron E, Lefel O and Cohen O: Thyroid carcinoma presenting as a hot nodule. Otolaryngol Head Neck Surg. 134:888–889. 2006. View Article : Google Scholar : PubMed/NCBI
15	Niepomniszcze H, Suárez H, Pitoia F, Pignatta A, Danilowicz K, Manavela M, Elsner B and Bruno OD: Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes. Thyroid. 16:497–503. 2006. View Article : Google Scholar : PubMed/NCBI
16	Uludag M, Yetkin G, Citgez B, Isgor A and Basak T: Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer. Hormones (Athens). 7:175–9. 2008. View Article : Google Scholar : PubMed/NCBI
17	Nishida AT, Hirano S, Asato R, Tanaka S, Kitani Y, Honda N, Fujiki N, Miyata K, Fukushima H and Ito J: Multifocal hyperfunctioning thyroid carcinoma without metastases. Auris Nasus Larynx. 35:432–436. 2008. View Article : Google Scholar : PubMed/NCBI
18	Bommireddipalli S, Goel S, Gadiraju R, Paniz-MondolFi A and DePuey EG: Follicular variant of papillary thyroid carcinoma presenting as a toxic nodule by I-123 scintigraphy. Clin Nucl Med. 35:770–775. 2010. View Article : Google Scholar : PubMed/NCBI
19	Azevedo MF and Casulari LA: Hyperfunctioning thyroid cancer: A five-year follow-up. Arq Bras Endocrinol Metabol. 54:78–80. 2010. View Article : Google Scholar : PubMed/NCBI
20	Giovanella L, Fasolini F, Suriano S and Mazzucchelli L: Hyperfunctioning solid/trabecular follicular carcinoma of the thyroid gland. J Oncol. 2010:2010. View Article : Google Scholar : PubMed/NCBI
21	Tfayli HM, Teot LA, Indyk JA and Witchel SF: Papillary thyroid carcinoma in an autonomous hyperfunctioning thyroid nodule: Case report and review of the literature. Thyroid. 20:1029–1032. 2010. View Article : Google Scholar : PubMed/NCBI
22	Karanchi H, Hamilton DJ and Robbins RJ: Hürthle cell carcinoma of the thyroid presenting as thyrotoxicosis. Endocr Pract. 18:e5–e9. 2012. View Article : Google Scholar : PubMed/NCBI
23	Nair CG, Jacob P, Babu M and Menon R: Toxic thyroid carcinoma: A new case. Indian J Endocrinol Metab. 16:668–670. 2012. View Article : Google Scholar : PubMed/NCBI
24	Ruggeri RM, Campenni A, Giovinazzo S, Saraceno G, Vicchio TM, Carlotta D, Cucinotta MP, Micali C, Trimarchi F, Tuccari G, et al: Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: Coexistent polymorphism of the TSHR and Gsα genes. Thyroid. 23:239–242. 2013. View Article : Google Scholar : PubMed/NCBI
25	Gabalec F, Svilias I, Plasilova I, Hovorkova E, Ryska A and Horacek J: Follicular variant of papillary carcinoma presenting as a hyperfunctioning thyroid nodule. J Pediatr Hematol Oncol. 36:e94–e96. 2014. View Article : Google Scholar : PubMed/NCBI
26	Kuan YC and Tan FH: Thyroid papillary carcinoma in a ‘hot’ thyroid nodule. QJM. 107:475–476. 2014. View Article : Google Scholar : PubMed/NCBI
27	Rees DO, Anthony VA, Jones K and Stephens JW: Follicular variant of papillary thyroid carcinoma: An unusual cause of thyrotoxicosis. BMJ Case Rep. 2015:2015. View Article : Google Scholar : PubMed/NCBI
28	Kadia BM, Dimala CA, Bechem NN and Aroke D: Concurrent hyperthyroidism and papillary thyroid cancer: A fortuitous and ambiguous case report from a resource-poor setting. BMC Res Notes. 9:3692016. View Article : Google Scholar : PubMed/NCBI
29	Girelli ME, Casara D, Rubello D, Pelizzo MR, Busnardo B and Ziliotto D: Severe hyperthyroidism due to metastatic papillary thyroid carcinoma with favorable outcome. J Endocrinol Invest. 13:333–337. 1990. View Article : Google Scholar : PubMed/NCBI
30	Mizukami Y, Michigishi T, Nonomura A, Yokoyama K, Noguchi M, Hashimoto T, Nakamura S and Ishizaki T: Autonomously functioning (hot) nodule of the thyroid gland. A clinical and histopathologic study of 17 cases. Am J Clin Pathol. 101:29–35. 1994. View Article : Google Scholar : PubMed/NCBI
31	Russo D, Tumino S, Arturi F, Vigneri P, Grasso G, Pontecorvi A, Filetti S and Belfiore A: Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab. 82:735–738. 1997. View Article : Google Scholar : PubMed/NCBI
32	Salvatori M, Rufini V, Corsello SM, Saletnich I, Rota CA, Barbarino A and Troncone L: Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine. J Nucl Biol Med. 37:69–72. 1993.PubMed/NCBI
33	Sundaraiya S, Dizdarevic S, Miles K, Quin J, Williams A, Wheatley T and Zammitt C: Unusual initial manifestation of metastatic follicular carcinoma of the thyroid with thyrotoxicosis diagnosed by technetium Tc 99m pertechnetate scan: Case report and review of literature. Endocr Pract. 15:458–462. 2009. View Article : Google Scholar : PubMed/NCBI
34	Damle NA, Bal C, Kumar P, Soundararajan R and Subbarao K: Incidental detection of hyperfunctioning thyroid cancer metastases in patients presenting with thyrotoxicosis. Indian J Endocrinol Metab. 16:631–636. 2012. View Article : Google Scholar : PubMed/NCBI
35	Gardner D and Ho SC: A rare cause of hyperthyroidism: Functioning thyroid metastases. BMJ Case Rep. 2014.(pii): bcr2014206468. 2014.PubMed/NCBI
36	Kunawudhi A, Promteangtrong C and Chotipanich C: A case report of hyperfunctioning metastatic thyroid cancer and rare I-131 avid liver metastasis. Indian J Nucl Med. 31:210–214. 2016. View Article : Google Scholar : PubMed/NCBI
37	Abs R, Verhelst J, Schoofs E and De Somer E: Hyperfunctioning metastatic follicular thyroid carcinoma in Pendred's syndrome. Cancer. 67:2191–2193. 1991. View Article : Google Scholar : PubMed/NCBI
38	Lorberboym M and Mechanick JI: Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma. J Nucl Med. 37:1532–1535. 1996.PubMed/NCBI
39	Yoshimura Noh J, Mimura T, Kawano M, Hamada N and Ito K: Appearance of TSH receptor antibody and hyperthyroidism associated with metastatic thyroid cancer after total thyroidectomy. Endocr J. 44:855–859. 1997. View Article : Google Scholar : PubMed/NCBI
40	Guglielmi R, Pacella CM, Dottorini ME, Bizzarri GC, Todino V, Crescenzi A, Rinaldi R, Panunzi C, Rossi Z, Colombo L and Papini E: Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: Treatment with (131)I and interstitial laser ablation. Thyroid. 9:173–177. 1999. View Article : Google Scholar : PubMed/NCBI
41	Basaria S and Salvatori R: Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease. J Endocrinol Invest. 25:639–642. 2002. View Article : Google Scholar : PubMed/NCBI
42	Orsolon P, Giachetti M, Lupi A, Salgarello M, Malfatti V and Zanco P: Pre-therapy hyperfunctioning follicular thyroid carcinoma evaluation with I-131 whole-body scan and with F-18 FDG PET/CT. Clin Nucl Med. 33:882–886. 2008. View Article : Google Scholar : PubMed/NCBI
43	Tan J, Zhang G, Xu W, Meng Z, Dong F, Zhang F, Jia Q and Liu X: Thyrotoxicosis due to functioning metastatic follicular thyroid carcinoma after twelve I-131 therapies. Clin Nucl Med. 34:615–619. 2009. View Article : Google Scholar : PubMed/NCBI
44	Nishihara E, Amino N and Miyauchi A: Fractionated radioiodine therapy for hyperthyroidism caused by widespread metastatic follicular thyroid carcinoma. Thyroid. 20:569–570. 2010. View Article : Google Scholar : PubMed/NCBI
45	Lim H, Devesa SS, Sosa JA, Check D and Kitahara CM: Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA. 317:1338–1348. 2017. View Article : Google Scholar : PubMed/NCBI
46	Salih AM, Kakamad FH and Nihad H: Hyperfunctioning papillary thyroid carcinoma: A case report with literature review. Int J Surg Case Rep. 26:202–204. 2016. View Article : Google Scholar : PubMed/NCBI
47	Pringle DR, Yin Z, Lee AA, Manchanda PK, Yu L, Parlow AF, Jarjoura D, La Perle KM and Kirschner LS: Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer. Endocr Relat Cancer. 19:435–446. 2012. View Article : Google Scholar : PubMed/NCBI